Richard C. Spielmann

Papers

Total Citations

H-Index

About

Richard C. Spielmann has made significant contributions to the field of clinical biochemistry and diagnostic methodology, with a particular focus on the analysis of glycosaminoglycans (GAGs) in human urine. His most cited work, "Urinary Glycosaminoglycan Excretion Quantified by an Automated Semimicro Method in Specimens Conveniently Transported from Around the Globe" (2002, 41 citations), exemplifies his commitment to developing practical, globally accessible diagnostic tools. This paper introduced an automated, semimicro method for quantifying urinary GAG excretion, addressing the critical need for reliable, transportable specimen analysis—a breakthrough that has facilitated large-scale studies and clinical screening for mucopolysaccharidoses and other metabolic disorders. Spielmann’s research has directly impacted the standardization of GAG measurement, enabling more accurate diagnosis and monitoring of lysosomal storage diseases. His work bridges laboratory innovation with real-world application, ensuring that even remote or resource-limited settings can benefit from advanced biochemical testing. Through his methodological advancements, Spielmann has strengthened the foundation of clinical diagnostics, leaving a lasting imprint on the field of metabolic disease detection and patient care.